Mayer Brown, OMM advise on Shanghai Haohai’s $302 mln HK IPO
BY Kanishk Verghese |
Mayer Brown JSM and O’Melveny & Myers have advised on biomedical materials maker Shanghai Haohai Biological Technology Co’s $302 million IPO on the Hong Kong Stock Exchange.